Europe — EMA
Omnipaque (Iohexol)
Iohexol, the active ingredient in Omnipaque, is a non‑ionic, non‑glucose iodinated contrast media presented as a diagnostic contrast agent for intravascular injection use.
Request sourcing
What is Iohexol?
Iohexol, the active ingredient in Omnipaque, is a non‑ionic, non‑glucose iodinated contrast media presented as a diagnostic contrast agent for intravascular injection use. It enhances imaging of vascular structures and organs during radiographic procedures. GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Iohexol used for?
Omnipaque is used in radiographic imaging to enhance visualization of various anatomical structures. - Cerebral angiography: Improves the detail of cerebral vessels and helps to detect vascular abnormalities. - Cardiac catheterisation: Enhances the outline of the heart and its blood flow patterns for diagnostic assessment. - Computed tomography (CT) scans: Provides a clear contrast between soft tissues and vascular structures so the scan is more accurate and diagnostic. - --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- - … .... .... ... ... .... ... ... ... ... ... ... ... ... ... ... t
t t
Product details
Related products

OMNIPAQUE 140 mg/mL
Iohexol · 140 mg/mL

OMNIPAQUE 180 mg/mL
Iohexol · 180 mg/mL

OMNIPAQUE 240 mg/mL
Iohexol · 240 mg/mL

OMNIPAQUE 240 mg/mL
Iohexol · 240 mg/mL